Patent: 10,400,043
✉ Email this page to a colleague
Summary for Patent: 10,400,043
Title: | Treatment of diffuse large-cell lymphoma with anti-CD20 antibody |
Abstract: | The present invention concerns methods for the treatment of diffuse large cell lymphoma by administration of an anti-CD20 antibody and chemotherapy. Particular embodiments include the administration of anti-CD20 antibody in combination with chemotherapy comprising CHOP (cyclophosphamide, hydroxydaunorubicin/doxorubicin, vincristine, and prednisone/prednisolone) and/or in combination with a transplantation regimen. |
Inventor(s): | White; Christine A. (Rancho Santa Fe, CA), Grillo-Lopez; Antonio J. (Rancho Santa Fe, CA) |
Assignee: | Biogen, Inc. (Cambridge, MA) |
Application Number: | 15/856,922 |
Patent Claims: | see list of patent claims |
Details for Patent 10,400,043
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
---|---|---|---|---|---|---|---|
Genentech, Inc. | RITUXAN | rituximab | Injection | 103705 | 11/26/1997 | ⤷ Try a Trial | 2019-08-11 |
Genentech, Inc. | RITUXAN HYCELA | rituximab and hyaluronidase human | Injection | 761064 | 06/22/2017 | ⤷ Try a Trial | 2019-08-11 |
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |